Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 11, 2024

BUY
$73.27 - $83.09 $3,150 - $3,572
43 Added 1.51%
2,891 $234,000
Q3 2023

Nov 09, 2023

SELL
$73.94 - $80.67 $15,823 - $17,263
-214 Reduced 6.99%
2,848 $213,000
Q2 2023

Jul 27, 2023

SELL
$76.01 - $86.7 $3,648 - $4,161
-48 Reduced 1.54%
3,062 $235,000
Q1 2023

Apr 13, 2023

BUY
$77.31 - $88.08 $13,683 - $15,590
177 Added 6.03%
3,110 $258,000
Q4 2022

Jan 25, 2023

BUY
$62.32 - $89.47 $182,784 - $262,415
2,933 New
2,933 $0

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Capstone Wealth Management Group, LLC Portfolio

Follow Capstone Wealth Management Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capstone Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capstone Wealth Management Group, LLC with notifications on news.